Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7457)
All Articles published online
|
Publishing Process of This Article
|
Feb 15, 2013 (publication date) through Feb 24, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Herath CB, Grace JA, Angus PW. Therapeutic potential of targeting the renin angiotensin system in portal hypertension. World J Gastrointest Pathophysiol 2013; 4(1): 1-11 [PMID: 23596549 DOI: 10.4291/wjgp.v4.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v4/i1/1.htm |
| Number | Citing Articles |
| 1 |
Manuel Morales-Ruiz, Juan Rodríguez-Vita, Jordi Ribera, Wladimiro Jiménez. PanVascular Medicine. 2015; : 3631 doi: 10.1007/978-3-642-37078-6_144
|
| 2 |
Amal M. Mahfoz, Aya Y. Gawish. Insight into the hepatoprotective, hypolipidemic, and antidiabetic impacts of aliskiren in streptozotocin-induced diabetic liver disease in mice. Diabetology & Metabolic Syndrome 2022; 14(1) doi: 10.1186/s13098-022-00935-5
|
| 3 |
Ibtesam A. Hilmi, Ali R. Abdullah. Anesthesia and Perioperative Care for Organ Transplantation. 2017; : 441 doi: 10.1007/978-1-4939-6377-5_34
|
| 4 |
Lakmie S Gunarathne, Harinda Rajapaksha, Nicholas Shackel, Peter W Angus, Chandana B Herath. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World Journal of Gastroenterology 2020; 26(40): 6111-6140 doi: 10.3748/wjg.v26.i40.6111
|
| 5 |
Tomer Adar, Yair Edden, Shimon Shteingart, Ami Ben Ya’acov, Mahmud Mahamid, Ellen Broide, Shimrit Shmorak, Ariella Bar-Gil Shitrit, Constantin Reinus, Eran Goldin. Portal hypertension is associated with modulation of regulatory T cells. European Journal of Inflammation 2016; 14(1): 40 doi: 10.1177/1721727X15622960
|
| 6 |
Julliane V. Joviano‐Santos, Artur Santos‐Miranda, Humberto C. Joca, Jader S. Cruz, Anderson J. Ferreira. Diminazene aceturate (DIZE) has cellular and in vivo antiarrhythmic effects. Clinical and Experimental Pharmacology and Physiology 2020; 47(2): 213 doi: 10.1111/1440-1681.13200
|
| 7 |
Lakmie S. Gunarathne, Indu G. Rajapaksha, Stephen Casey, Tawar Qaradakhi, Anthony Zulli, Harinda Rajapaksha, Jonel Trebicka, Peter W. Angus, Chandana B. Herath. Mas‐related G protein‐coupled receptor type D antagonism improves portal hypertension in cirrhotic rats. Hepatology Communications 2022; 6(9): 2523 doi: 10.1002/hep4.1987
|
| 8 |
Chandana B. Herath, Kai Y. Mak, Peter W. Angus. The Protective Arm of the Renin Angiotensin System (RAS). 2015; : 239 doi: 10.1016/B978-0-12-801364-9.00034-1
|
| 9 |
Chang-qing Zhao, Yang Zhou, Jian Ping, Lie-ming Xu. Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. Journal of Integrative Medicine 2014; 12(5): 401 doi: 10.1016/S2095-4964(14)60039-X
|
| 10 |
Marco Di Pascoli, Vincenzo La Mura. Renin-angiotensin-aldosterone system in cirrhosis: There’s room to try!. Digestive and Liver Disease 2019; 51(2): 297 doi: 10.1016/j.dld.2018.07.038
|
| 11 |
Indu Rajapaksha. Liver Fibrosis, Liver Cancer, and Advances in Therapeutic Approaches. Livers 2022; 2(4): 372 doi: 10.3390/livers2040028
|
| 12 |
Manuel Morales-Ruiz, Juan Rodríguez-Vita, Jordi Ribera, Wladimiro Jiménez. PanVascular Medicine. 2014; : 1 doi: 10.1007/978-3-642-37393-0_144-1
|
| 13 |
Ahmed A. Shaaban, Mohamed E. Shaker, Khaled R. Zalata, Hassan A. El-kashef, Tarek M. Ibrahim. Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3. Chemico-Biological Interactions 2014; 207: 81 doi: 10.1016/j.cbi.2013.10.008
|
| 14 |
Adriano J. Pereira, Victor Jeger, René Fahrner, Siamak Djafarzadeh, Michael Lensch, Jukka Takala, Stephan M. Jakob. Interference of angiotensin II and enalapril with hepatic blood flow regulation. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 307(6): G655 doi: 10.1152/ajpgi.00150.2014
|
| 15 |
Nahla E El‐Ashmawy, Hoda A El‐Bahrawy, Maha M Shamloula, Amera O Ibrahim. Antifibrotic effect of AT‐1 blocker and statin in rats with hepatic fibrosis. Clinical and Experimental Pharmacology and Physiology 2015; 42(9): 979 doi: 10.1111/1440-1681.12446
|